Skip to content

    Research Use Only

    This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.

    🔬 100K+ researchers trust BodyHackGuide — Join r/BodyHackGuide
    AdaptogenPreclinical

    Fadogia Agrestis Dosage Guide: Protocols, Calculator & Safety

    Everything you need to know about Fadogia Agrestis dosing — protocols, safety, and where to buy.

    Dosage Calculator

    Calculate exact dosing for Fadogia Agrestis.

    Dosing Protocols

    Beginner

    Beginner Protocol (first-time Fadogia users with cautious approach):

    Honest precursor recommendation: Before starting Fadogia specifically, ensure you have optimized the evidence-based foundations:

    • Adequate sleep (7-9 hours nightly)
    • Regular resistance training
    • Adequate zinc (15-30mg daily) and vitamin D (2000-5000 IU daily, with blood level check)
    • Magnesium adequacy (300-400mg daily)
    • Body composition management
    • Alcohol moderation, stress management
    • Consider Tongkat Ali 200mg daily (LJ100 or Physta standardized — substantially stronger evidence than Fadogia)

    If these foundations are in place and you still want to try Fadogia:

    Form and dose: Fadogia agrestis stem extract (if possible, standardized, though standardization claims for Fadogia are essentially unverifiable). Start at 300-400mg once daily, taken in the morning with food.

    Duration: 4 weeks on, followed by at least 4 weeks off. This is a trial, not a commitment.

    Baseline labs before starting:

    • Comprehensive metabolic panel (includes AST, ALT, BUN, creatinine)
    • Testosterone (total and free), SHBG, estradiol, LH, FSH
    • Note subjective symptoms, libido, energy, mood, and training performance

    Follow-up labs at 4 weeks (before cycling off):

    • Repeat comprehensive metabolic panel — confirm no liver or kidney enzyme elevation
    • Repeat hormone panel — observe whether expected testosterone effects occurred

    Follow-up labs at 8 weeks (after cycle off):

    • Repeat hormone panel — observe whether HPG axis recovered to baseline
    • Assess whether benefits were sustained off the compound or regressed

    Subjective tracking throughout:

    • Daily or weekly ratings of libido, energy, training performance, mood, sleep quality
    • Honest assessment of whether changes are clinically meaningful or subtle/ambiguous

    Red flags warranting immediate discontinuation:

    • Nausea persisting more than a few days
    • Abdominal pain, especially right upper quadrant
    • Yellow discoloration of skin or eyes (jaundice — liver injury)
    • Dark urine or clay-colored stools (liver injury)
    • Reduced urine output or peripheral edema (kidney injury)
    • Severe mood changes, aggression, or anxiety
    • Any new symptom significantly impacting quality of life

    Quality selection:

    • Choose products from brands with third-party testing and transparent sourcing
    • Look for DNA-authenticated or microscopically-verified plant identification
    • Prefer stem extracts (consistent with the rodent research material) over leaf, root, or whole-plant preparations
    • Avoid "proprietary blend" products that obscure actual Fadogia dose
    • Expect to pay more for quality-assured Fadogia — this is not a commodity supplement yet

    Honest expectation calibration:

    • You are taking a supplement with zero rigorous human clinical trials
    • Subjective effects may reflect placebo
    • Effects that do occur may not persist beyond the cycle
    • "Dramatic" effects likely reflect expectation or adulteration rather than the herb itself
    • Modest effects are the more likely real-world outcome
    • No effect at all is also a plausible outcome — don't escalate dose if you notice nothing; consider discontinuing

    Decision point at end of first cycle: If clear, meaningful benefits occurred during the cycle and persisted at least partly after cycling off; and labs remain normal; and cost is acceptable — continuing with periodic cycling is reasonable. If no noticeable benefits, discontinue and save money/exposure.

    Standard

    Intermediate Protocol (users with prior Fadogia experience, seeking optimization):

    Form and dose: 400-600mg Fadogia agrestis stem extract daily, typically as a single morning dose with food, or split as 300mg morning + 300mg midday.

    Duration: 6-8 weeks on / 4 weeks off. More aggressive cycling than beginner but still prioritizes safety.

    Stacking approach:

    "Huberman stack" implementation:

    • Fadogia agrestis 400-600mg in the morning with breakfast
    • Tongkat Ali 200mg (LJ100 or Physta) in the morning with breakfast
    • Both supplements for the 6-8 week "on" cycle; Tongkat Ali can continue through the off weeks (it has substantially better long-term safety data than Fadogia)

    Broader testosterone-support stack:

    Male sexual function stack:

    • Morning: Fadogia 400-600mg + Tongkat Ali 200mg
    • Pre-activity: L-citrulline 6g (60-90 minutes before)
    • Foundation as above

    Cycling strategy:

    • 8 weeks on, 4 weeks off, repeated quarterly → 32 weeks on per year
    • Alternative: 6 weeks on, 3 weeks off, repeated → similar annual exposure
    • Track subjective and objective response each cycle; if benefits diminish over successive cycles, may reflect tolerance or HPG axis adaptation — extend off-cycle period

    Monitoring:

    • Baseline and every 12-16 weeks: comprehensive metabolic panel, complete blood count, hormone panel (total T, free T, SHBG, estradiol, LH, FSH, prolactin, DHEA-S, TSH)
    • Sleep quality tracking (subjective and ideally with Oura/Whoop/similar for objective data)
    • Libido and sexual function ratings (validated scales like IIEF for men, FSFI for women)
    • Training logs — strength and body composition changes
    • Mood assessment (PHQ-9, GAD-7 if relevant)

    Signs you're getting value from Fadogia specifically (as opposed to placebo or the other stack components):

    • Clear improvement during on-cycles that regresses during off-cycles → suggests the supplement is doing something
    • Objective hormone changes correlating with on/off cycling → stronger evidence of real effect
    • Consistency across multiple cycles → reliability of the effect

    Signs Fadogia may not be adding value:

    • No subjective difference between on-cycle and off-cycle
    • Hormone panels unchanged across cycles
    • Benefits attributable to concurrent Tongkat Ali or lifestyle improvements
    • Adverse effects outweigh benefits

    Adverse event protocol:

    • Mild GI symptoms: take with larger meal, consider split dosing
    • Mild sleep disturbance: move dosing to early morning only
    • Mild mood changes: track pattern and severity; if persistent, discontinue
    • Any sign of hepatic or renal dysfunction: immediate discontinuation and medical evaluation
    • Any severe adverse effect: immediate discontinuation

    Integration with medical care: If using Fadogia as part of an attempt to address symptomatic low testosterone, clinical evaluation by a physician (ideally endocrinology or urology) is recommended regardless. Supplements are not substitutes for proper medical workup of hypogonadism.

    Advanced

    Advanced Protocol (experienced users with clear risk tolerance and established supplement tracking):

    Disclaimer: An "advanced" Fadogia protocol is more about knowledge and monitoring than higher doses. Given the thin evidence base and rodent toxicity signal, "aggressive" Fadogia use is not scientifically justified regardless of user experience. The recommendations below represent the upper bound of reasonable experimentation, not maximization.

    Form and dose: 600-800mg Fadogia agrestis stem extract daily. Upper end of this range should be reserved for users with verified clean lab results at lower doses and clear evidence of benefit. Doses above 800mg/day are not recommended given the rodent toxicity at comparably scaled doses.

    Duration: Maximum 8 weeks continuous use, followed by mandatory 4-week off-cycle. Target total annual exposure of 24-32 weeks on-cycle.

    Comprehensive male vitality stack (for users committed to multi-component optimization):

    Morning:

    Midday/Lunch:

    • Fadogia agrestis 200-300mg (remainder of daily total)
    • Boron 6mg

    Evening:

    Training days (pre-workout):

    Foundation (with meals):

    • Comprehensive multivitamin
    • Omega-3 2-3g EPA+DHA

    Comprehensive monitoring schedule:

    Every 4 weeks during on-cycles:

    • Comprehensive metabolic panel (CMP)
    • Hepatic function panel (LFTs)

    Every 8 weeks:

    • Complete hormone panel: total testosterone, free testosterone, bioavailable testosterone, SHBG, estradiol, LH, FSH, prolactin, DHEA-S, cortisol (morning), TSH, free T4
    • Complete blood count (CBC)
    • Lipid panel

    Every 12 weeks:

    • PSA (if age ≥40 or family history)
    • Comprehensive thyroid panel including antibodies if relevant
    • Fasting insulin, glucose, HbA1c

    Annually:

    • Complete physical examination
    • Cardiovascular risk assessment
    • Blood pressure monitoring (should be routine at home)
    • Body composition assessment (DEXA scan preferred)

    Fertility considerations:

    • If actively pursuing conception: discontinue Fadogia 3+ months before conception attempts given testicular toxicity signal
    • Semen analysis before and after cycles if fertility is a priority
    • Consider alternative testosterone support (evidence-based, less toxicity signal) during fertility-focused periods

    Integration with TRT users: Fadogia is NOT recommended for users on testosterone replacement therapy. The HPG axis is already exogenously managed on TRT; adding a supplement that supposedly stimulates endogenous production is redundant, potentially disruptive to TRT dose titration, and adds unnecessary risk.

    Integration with performance-enhancing drug (PED) users: Similarly not recommended. If using anabolic-androgenic steroids (even "cycled" use), adding Fadogia is redundant and risky.

    Advanced cycling strategies:

    "Double-blind self-experiment" for motivated users:

    • Prepare identical capsules filled with Fadogia or placebo (microcrystalline cellulose)
    • Have a partner or spouse randomize which bottle contains which
    • Track outcomes over multiple weeks without knowing which is active
    • Unblind only after completion
    • This is the closest an individual can come to a controlled trial and addresses placebo/expectation concerns

    When to discontinue Fadogia permanently (not just cycle off):

    • Any confirmed hepatic or renal injury
    • Any cardiovascular adverse event
    • Persistent mood deterioration not resolved with cycling off
    • No detectable benefit after 2-3 complete on/off cycles
    • Development of hormone-sensitive condition
    • Cost-benefit assessment suggests resources better deployed elsewhere

    Long-term perspective:

    Users should remember that the goal of "testosterone support" is ultimately health, quality of life, physical performance, and sexual function — not optimizing hormone panel numbers in isolation. If Fadogia is not meaningfully improving these target outcomes, no amount of monitoring or dose titration justifies continued use. Evidence-based medicine favors interventions with clear benefit demonstrated in human trials; Fadogia remains outside that evidentiary frame regardless of individual user enthusiasm.

    Commonly Stacked With

    Fadogia agrestis is most commonly stacked with other male vitality and testosterone-support herbs, though — given the thin evidence base for Fadogia itself — these stacks should be viewed as experimental combinations rather than evidence-based protocols.

    The iconic "Huberman stack" (Fadogia + Tongkat Ali):

    • Fadogia Agrestis + Tongkat Ali: This is the most famous Fadogia stack, popularized by Dr. Andrew Huberman on his podcast. The pairing logic: Tongkat Ali works primarily by reducing SHBG and cortisol (increasing free testosterone from existing total testosterone), while Fadogia purportedly increases testosterone production. Combining different mechanisms theoretically produces complementary effects. In practice, Tongkat Ali is the workhorse of this stack with stronger evidence (LJ100 or Physta 200mg daily for 12 weeks), while Fadogia is the speculative addition (400-600mg daily for 8 weeks on / 4 weeks off). This stack is reasonable for experimentally-inclined users with realistic expectations.

    Testosterone-support stacks:

    • Fadogia + Ashwagandha (KSM-66): Evidence-based foundation (ashwagandha for stress/cortisol/testosterone in stressed men) with speculative addition (Fadogia). Sensible approach that prioritizes the better-evidenced herb.

    • Fadogia + Mucuna Pruriens: Mucuna provides dopaminergic support that may contribute to libido through central mechanisms; Fadogia provides purported androgenic support. Short-cycle use only.

    • Fadogia + Shilajit: Shilajit has modest testosterone evidence and broad rasayana effects; Fadogia adds speculative androgenic support. Limit duration.

    • Fadogia + Maca: Combines Maca's libido/vitality evidence with Fadogia. Reasonable short-cycle combination.

    Comprehensive testosterone support protocols:

    • Foundational (evidence-based): Tongkat Ali 200mg + Ashwagandha KSM-66 600mg + Zinc 15-30mg + Vitamin D 2000-5000 IU + Magnesium 400mg + Boron 3-6mg + DHEA (if clinically indicated). This foundation has meaningfully stronger evidence than any herb-only stack.

    • Experimental addition to foundation: Add Fadogia 400-600mg daily for 4-8 weeks, then discontinue and assess whether it added noticeable benefit. Most users will find it hard to distinguish Fadogia's effects from the foundation.

    Sexual function / libido stacks:

    • Fadogia + L-Citrulline: L-Citrulline provides evidence-based nitric oxide / erectile function support; Fadogia adds purported androgenic effects.

    • Fadogia + Horny Goat Weed + Tribulus: "Kitchen sink" libido/male-function herbal stack; limited evidence for the combination specifically, but popular in "natural male enhancement" formulas.

    • Fadogia + Ginseng (Panax): Ginseng has evidence for ED and sexual function; Fadogia is speculative complement.

    What to avoid combining with Fadogia:

    • Testosterone replacement therapy (TRT): Redundant and may confound hormone monitoring; potential HPG axis disruption.

    • Anabolic-androgenic steroids: Do not stack.

    • Pharmaceutical PDE5 inhibitors without medical guidance: While ED supplements + PDE5i may be combined under physician supervision, unsupervised combination raises priapism risk.

    • Multiple hepatotoxic herbs or supplements simultaneously: Kava, pennyroyal, comfrey, high-dose green tea extract — given Fadogia's liver injury signal, don't compound it.

    • High-dose acetaminophen (paracetamol): Given Fadogia's liver injury signal, additive hepatotoxicity risk.

    • Chronic NSAIDs: Given Fadogia's kidney injury signal, additive nephrotoxicity risk.

    • Multiple "testosterone booster" products simultaneously: Redundant, more expensive, and increases adulterant exposure risk without clearly additive benefit.

    Timing considerations:

    • Morning dosing: Generally preferred to avoid sleep disturbance; also aligns with natural testosterone circadian rhythm.

    • With food: Reduces GI side effects; possibly affects absorption (unclear for Fadogia specifically).

    • Pre-workout: Some users take Fadogia 60-90 minutes before training under the theory that elevated testosterone supports training response. Evidence for this specific use is absent.

    Cycling patterns (strongly recommended given toxicity signal):

    • Aggressive cycling: 4 weeks on, 4 weeks off (half-and-half). Most cautious approach, recommended for first-time users.

    • Moderate cycling: 6 weeks on, 3 weeks off. Balance between experimentation and safety.

    • Extended cycling: 8 weeks on, 4 weeks off. Maximum recommended continuous use duration.

    • Avoid: continuous year-round use without breaks.

    Budget and priority framework:

    If supplement budget is limited, prioritize spending on: (1) evidence-based foundations (ashwagandha, tongkat ali, zinc, vitamin D, magnesium, creatine for athletes); (2) lifestyle optimization (better sleep equipment, quality food, training program); (3) only add Fadogia if budget and interest remain after covering the evidence-based priorities. Fadogia is not a foundational supplement.

    Side Effects & Safety

    **The reported side effect profile of Fadogia agrestis in humans is poorly characterized given the absence of controlled human trials**. What is known comes from (a) extrapolation from rodent toxicology studies, (b) anecdotal user reports on supplement forums and social media, and (c) theoretical concerns based on known phytochemistry. Users should be aware that unknown unknowns are a real concern with this compound. **Anecdotally reported side effects in humans:** - **Gastrointestinal distress**: Nausea, stomach upset, cramping, and diarrhea are the most commonly reported acute adverse effects, particularly at higher doses or on an empty stomach. Taking Fadogia with food substantially reduces GI symptoms. - **Headache**: Some users report mild to moderate headaches, particularly when starting supplementation or at higher doses. Mechanism unclear. - **Sleep disturbance and restlessness**: Reports of insomnia, vivid dreams, and general restlessness, particularly with evening dosing. Some users compare these effects to the CNS stimulation of stimulants. - **Anxiety or agitation**: Some users report increased anxiety, agitation, or irritability. This is particularly concerning given the unknown CNS mechanisms of Fadogia. - **Increased aggression or "edgy" feeling**: Some users describe mood changes that may reflect androgenic effects or general CNS stimulation. - **Muscle cramps**: Occasional reports, possibly related to electrolyte or mineral effects. - **Libido paradox**: Interestingly, some users report DECREASED libido with chronic Fadogia use, contrary to the aphrodisiac reputation. This may reflect HPG axis downregulation with sustained exogenous stimulation — a pattern seen with various testosterone-enhancing agents. **Safety concerns from rodent toxicology (which may or may not apply to humans):** - **Hepatotoxicity (liver damage)**: The Yakubu 2008 rat studydocumented dose-dependent hepatic injury at the same doses that elevated testosterone in the short-term study. Whether analogous hepatotoxicity occurs in humans at commonly used supplement doses is unknown, but the rodent data warrants caution. Patients with pre-existing liver disease should avoid Fadogia; healthy users on extended Fadogia courses should consider periodic liver function monitoring (AST, ALT, bilirubin). - **Nephrotoxicity (kidney damage)**: Same Yakubu 2008 study documented dose-dependent renal injury in rats. Mechanism unclear. Patients with kidney disease should avoid Fadogia; healthy users should consider periodic renal function monitoring (creatinine, BUN, estimated GFR). - **Testicular toxicity**: Perhaps the most ironic and concerning finding of the rodent toxicology: the same organ Fadogia is purported to "support" shows histological damage at doses that elevated testosterone in short-term studies. This raises the question of whether "testosterone boosting" comes at the cost of testicular health with prolonged use. Cycling (4-8 weeks on, 4+ weeks off) is strongly recommended as a precaution. - **Hematologic effects**: Rodent studies showed changes in blood parameters that could reflect bone marrow effects or direct hematologic toxicity. **Population-specific concerns:** - **Pregnancy and lactation**: Contraindicated absolutely. No safety data; traditional use was not in pregnant/lactating women; theoretical hormonal effects could be teratogenic. - **Hormone-sensitive cancers** (prostate, breast, testicular): Avoid. The purported testosterone-elevating effect (whether real or not) would be contraindicated. - **Liver or kidney disease**: Avoid given the rodent toxicity signal in these organs. - **Children and adolescents**: Avoid. Developing reproductive systems should not be exposed to uncharacterized hormonally-active compounds. - **Men planning fertility/conception**: Use with caution or avoid. The testicular toxicity signal in rodents is concerning; theoretical suppression of endogenous HPG axis could impair fertility. - **Hypertension or cardiovascular disease**: Use with caution; effects on blood pressure and cardiovascular function in humans are unknown. - **Mental health conditions** (anxiety, depression, bipolar): Use with caution given anecdotal reports of mood changes. **Drug interactions (theoretical — essentially no formal studies):** - **Testosterone replacement therapy (TRT)**: Redundant and potentially concerning for HPG axis disruption. Do not combine. - **Other testosterone-enhancing supplements** ([Tongkat Ali](/compound/tongkat-ali), [ashwagandha](/compound/ashwagandha), [Tribulus](/compound/tribulus-terrestris), DAA, etc.): Theoretical additive effects; use with caution and prefer not stacking multiple testosterone-claimed supplements simultaneously. - **Anabolic-androgenic steroids (prescription or non-medical)**: Do not combine. - **Hepatotoxic medications**: Avoid given the liver injury signal. Examples include acetaminophen at high doses, isoniazid, methotrexate, amiodarone, statins in susceptible individuals. - **Nephrotoxic medications**: Avoid given the kidney injury signal. Examples include NSAIDs in high doses or chronically, aminoglycoside antibiotics, cyclosporine, certain chemotherapy agents. - **Antihypertensive medications**: Unknown interactions; monitor blood pressure. - **Antidepressants and anxiolytics**: Theoretical interactions given CNS effects; use with caution. - **Blood thinners**: Unknown interactions; monitor for bleeding. **Quality and safety considerations specific to Fadogia:** - **Plant misidentification**: Fadogia agrestis must be distinguished from related *Fadogia* species and from unrelated plants that may be marketed or sold as Fadogia. DNA-authenticated products offer stronger identification guarantee. - **Contamination**: West African plant supply chains may have inconsistent contamination testing for heavy metals, pesticides, and microbial contaminants. - **Adulteration with pharmaceutical hormones or steroids**: While less documented than for Tribulus, the possibility exists, particularly for products aggressively marketing "dramatic testosterone effects." - **Third-party testing**: The infrastructure for Fadogia product testing is less developed than for mainstream supplements. Consumers should preferentially choose brands with documented third-party analytical testing. **Monitoring recommendations for users:** - Baseline comprehensive metabolic panel (CMP) including liver enzymes, BUN, creatinine - Baseline testosterone (total and free), SHBG, estradiol, LH - Follow-up CMP at 6-8 weeks to monitor liver and kidney function - Follow-up hormone panel at 8-12 weeks to assess whether anticipated effects occurred - Discontinue at the first sign of hepatic dysfunction (jaundice, dark urine, RUQ pain, transaminitis) - Discontinue at signs of renal dysfunction (oliguria, peripheral edema, elevated creatinine) - Cycling: strongly recommended — 4-8 weeks on, 4+ weeks off - Avoid prolonged continuous use (>3-4 months without breaks)

    Contraindications

    **Fadogia agrestis is contraindicated or requires significant caution in the following circumstances**: **Absolute contraindications**: - **Pregnancy**: Contraindicated absolutely. No safety data exists in pregnancy; traditional use has not been in pregnant women; theoretical hormonal effects are concerning for fetal development; testicular toxicity findings in rodents raise broader reproductive safety concerns. Avoid throughout pregnancy and when planning pregnancy. - **Lactation**: Contraindicated. Absolutely no safety data; transmission through breast milk unknown. Avoid during breastfeeding. - **Children and adolescents (under 18)**: Contraindicated. Developing endocrine systems should not be exposed to uncharacterized hormonally-active compounds; no pediatric safety or efficacy data. - **Active hepatic disease**: Contraindicated given the rodent hepatotoxicity signal. Patients with active hepatitis, cirrhosis, NAFLD with significant enzyme elevation, or other liver disease should not use Fadogia. - **Active renal disease**: Contraindicated given the rodent nephrotoxicity signal. Patients with chronic kidney disease (stage 3 or worse), acute kidney injury, or nephrotic syndrome should not use Fadogia. - **Hormone-sensitive cancers (active)**: Contraindicated. Active prostate cancer, hormone-sensitive breast cancer, testicular cancer, and related conditions should not be exposed to supplements purported to elevate testosterone (whether the effect is real or not). **Strong cautions (avoid or use only with physician supervision)**: - **History of prostate cancer**: Even in remission, caution warranted. - **Benign prostatic hyperplasia (BPH) with significant symptoms**: Possible complication of urinary symptoms. - **Active fertility pursuit** (men planning conception): The testicular toxicity signal in rodents makes Fadogia ill-suited for men trying to conceive. Discontinue at least 3 months (one spermatogenesis cycle) before conception attempts. - **Cardiovascular disease**: Coronary artery disease, heart failure, uncontrolled hypertension — given unknown cardiovascular effects in humans and general caution advised for uncharacterized herbal supplements. - **Psychiatric disorders**: Bipolar disorder, anxiety disorders, history of psychosis, major depressive disorder — given anecdotal reports of mood changes and CNS effects. - **Diabetes**: Unknown effects on glucose metabolism; monitor blood glucose if used. - **Bleeding disorders or upcoming surgery**: Unknown effects on coagulation; discontinue at least 2 weeks before elective surgery. - **Elderly patients**: Particularly caution given unknown pharmacokinetics and higher baseline risk of hepatic/renal compromise. - **Polypharmacy**: Users on multiple medications face compounded interaction risk given Fadogia's uncharacterized pharmacology. **Drug interactions (theoretical, essentially unstudied)**: - **Testosterone replacement therapy (TRT)**: Avoid combination. Redundant hormonal stimulation; potential disruption of TRT dose titration and monitoring. - **Anabolic-androgenic steroids** (medical or non-medical): Do not combine. - **Other "testosterone booster" supplements**: Avoid stacking multiple testosterone-claimed supplements simultaneously; theoretical additive effects with unknown safety. - **Hepatotoxic medications**: Acetaminophen in high doses, methotrexate, isoniazid, amiodarone, statins in susceptible individuals, certain antiretrovirals, certain antibiotics — avoid given Fadogia's hepatic injury signal. - **Nephrotoxic medications**: NSAIDs (particularly at high dose or chronically), aminoglycoside antibiotics, cyclosporine/tacrolimus, certain chemotherapy agents — avoid given Fadogia's renal injury signal. - **Pharmaceutical PDE5 inhibitors** (sildenafil, tadalafil, vardenafil, avanafil): Theoretical additive pro-erectile effects; unsupervised combination raises priapism risk. - **Anticoagulants and antiplatelet agents**: Unknown interactions; use with caution. - **Antidepressants and anxiolytics**: Theoretical interactions given CNS effects; monitor if combined. - **Antihypertensive medications**: Unknown blood pressure effects in humans; monitor. - **Diabetes medications**: Unknown glucose effects; monitor. - **Immunosuppressants**: Avoid in transplant recipients or autoimmune disease patients given uncharacterized immune effects. - **Monoamine oxidase inhibitors**: Theoretical concern given unknown CNS mechanisms; avoid combination. - **Other hepatotoxic or nephrotoxic herbs**: Kava, pennyroyal, comfrey, chaparral, high-dose [green tea](/compound/green-tea-egcg) extract (hepatotoxic), chronic aristolochic-acid-containing herbs (nephrotoxic) — avoid stacking. **Quality and authentication-related contraindications**: - **Products without third-party testing**: Not recommended for anyone given adulteration and identification risks. - **"Proprietary blend" products**: Cannot verify actual Fadogia content; avoid. - **Products from unknown manufacturers without verifiable sourcing**: Avoid. - **Extremely inexpensive products**: Likely under-dosed, adulterated, or misidentified; avoid. - **Products making extreme marketing claims** (dramatic muscle gain, specific testosterone percentages, "legal steroid alternative"): Likely adulterated with actual hormonal agents; avoid. **Populations where Fadogia is particularly unsuitable**: - Healthy young men with normal testosterone who are hoping for dramatic effects — better served by lifestyle optimization and evidence-based supplements - Athletes subject to WADA or similar drug testing — adulteration risk is real; safer to avoid entirely - Individuals on complex medication regimens — too many potential interactions - Those with multiple organ system concerns (hepatic + renal + cardiovascular disease) - Anyone unwilling to do baseline labs and periodic monitoring - Users seeking a "quick fix" for low testosterone symptoms — proper medical evaluation should come before herbal experimentation **When to discontinue (immediately and permanently in most cases)**: - Any sign of hepatic dysfunction: jaundice, dark urine, light stools, right upper quadrant pain, unexplained fatigue with transaminitis - Any sign of renal dysfunction: oliguria, peripheral edema, elevated creatinine - Cardiovascular symptoms: chest pain, dyspnea, palpitations, new arrhythmia - Prolonged erection (>4 hours — urologic emergency) - Significant mood deterioration - Severe anxiety, agitation, or aggression - Any allergic reaction - Development of a contraindicating condition - Failure to demonstrate benefit after 2-3 complete cycles - When pursuing pregnancy/conception (discontinue at least 3 months beforehand) - Before elective surgery (discontinue at least 2 weeks) - If adding any medication with potential hepatic or renal interaction **Bottom-line framing**: Fadogia agrestis is a supplement at the experimental frontier of herbal testosterone support, with more unknowns than knowns about its human pharmacology and safety. Users who choose to experiment should do so with rigorous monitoring, clear cycling protocols, realistic expectations, and willingness to discontinue at the first sign of concern. This is not a supplement for casual unmonitored consumption, and it is not for users who would be disappointed to learn their results are attributable to placebo rather than the compound itself.

    Check interactions with the Interaction Checker →

    Additional Notes

    Fadogia agrestis dosing guidance (based on thin evidence — most dosing recommendations are extrapolated rather than trial-derived):

    Commercial supplement dosing (where most market products are positioned):

    • 400-600mg Fadogia agrestis stem extract daily
    • Some products go up to 1000mg/day; dosing above 800mg/day is not recommended given rodent toxicity signal

    Dose extrapolation from rodent research:

    • Yakubu 2005 showed significant effects at 50-100mg/kg in rats
    • Allometric scaling (dividing rodent dose by ~6-7 for human equivalent) suggests 7-15mg/kg in humans
    • For a 75kg person: approximately 500-1100mg
    • However, human bioavailability and response is genuinely unknown

    Dose by goal:

    • Testosterone/libido support (experimental use): 400-600mg daily, 8 weeks on / 4 weeks off
    • Sexual function support (anecdotal use): 400-600mg daily, potentially dosed before activity
    • "Natural T-booster" stack component: typically 400mg daily as one of several components

    Form options:

    • Standardized stem extract (preferred): Commercial products typically list a saponin or generic "extract ratio" but standardization is not rigorous given the poor characterization of active compounds
    • Whole stem powder: Generally inferior to extracts for consistency
    • Tincture: Uncommon form; dosing variable
    • Whole plant extract: Uncommon; less aligned with research material (which was stem-specific)

    Timing:

    • Morning dosing is typically preferred given possible stimulant-like effects that can disrupt sleep
    • With food is recommended to reduce GI side effects
    • Pre-workout (60-90 minutes before training) is anecdotally reported by some users as helpful for training performance, though evidence for acute ergogenic effects is absent
    • Split dosing (AM + lunch) may smooth exposure; evening doses generally avoided

    Cycling (strongly recommended):

    • 4-8 weeks on / 4 weeks off at minimum
    • Maximum 8 weeks continuous use per cycle
    • Annual total: 24-32 weeks on-cycle (leaves substantial off-time for HPG axis recovery and organ recuperation)
    • Avoid continuous year-round use

    Dosing for special populations:

    • First-time users: Start at 300mg daily for first week; increase to 400mg if tolerated
    • Older men (>50): Start low (300-400mg); monitor more carefully for adverse effects
    • Smaller body size users: Dose proportionally lower (consider 300-400mg rather than 600mg)
    • Larger body size users: Standard commercial dosing (400-600mg) may be adequate; limited evidence supports higher dosing
    • Women: Limited data; if used at all, consider much lower doses (100-200mg) given risk/benefit asymmetry (testosterone-elevating effects may be unwelcome in most women)

    Dose quality — what to look for:

    • Clear declaration of mg Fadogia agrestis stem extract per capsule/dose
    • Extract ratio specified (e.g., 10:1, 20:1)
    • Third-party testing for identity, purity, and contamination
    • DNA authentication or microscopy-verified plant identification
    • No "proprietary blend" that obscures actual Fadogia content
    • Reputable manufacturer with verifiable sourcing

    Dose quality — what to avoid:

    • Products with vague claims like "equivalent to 5000mg of Fadogia" without extract specifications
    • Multi-ingredient testosterone booster formulas that include Fadogia but don't list its specific dose
    • Products with no third-party testing information
    • Products with extreme marketing claims (guaranteed muscle gain, "as effective as steroids," etc.)
    • Extremely cheap products from unknown manufacturers (Fadogia at genuine quality cannot be extremely cheap given supply chain costs)

    Expected cost reference: Quality Fadogia products typically cost $25-50/month at the 400-600mg/day range. Products substantially cheaper than this are probably under-dosed, adulterated, or misidentified. Products substantially more expensive are likely charging a quality premium that may or may not be justified.

    What dosing does NOT establish:

    • Whether Fadogia actually works in humans at any dose
    • What the "correct" dose for your specific biology is
    • Whether more is better, or whether a plateau/inverted-U exists
    • Long-term safety at any sustained dose
    • Interaction doses with other supplements or medications

    User responsibility: Given the thin evidence base, Fadogia dosing is fundamentally experimental. Users should monitor labs, track subjective response, and be willing to discontinue if benefits are not clear or if any safety concern emerges.

    Frequently Asked Questions

    What is the recommended Fadogia Agrestis dosage?

    Dosage for Fadogia Agrestis varies by protocol. Consult a qualified healthcare provider.

    How often should I take Fadogia Agrestis?

    Administration frequency depends on the specific protocol. Consult current research literature.

    Does Fadogia Agrestis need to be cycled?

    Cycling requirements depend on the protocol. Follow established research guidelines.

    What are Fadogia Agrestis side effects?

    **The reported side effect profile of Fadogia agrestis in humans is poorly characterized given the absence of controlled human trials**. What is known comes from (a) extrapolation from rodent toxicology studies, (b) anecdotal user reports on supplement forums and social media, and (c) theoretical concerns based on known phytochemistry. Users should be aware that unknown unknowns are a real concern with this compound. **Anecdotally reported side effects in humans:** - **Gastrointestinal distress**: Nausea, stomach upset, cramping, and diarrhea are the most commonly reported acute adverse effects, particularly at higher doses or on an empty stomach. Taking Fadogia with food substantially reduces GI symptoms. - **Headache**: Some users report mild to moderate headaches, particularly when starting supplementation or at higher doses. Mechanism unclear. - **Sleep disturbance and restlessness**: Reports of insomnia, vivid dreams, and general restlessness, particularly with evening dosing. Some users compare these effects to the CNS stimulation of stimulants. - **Anxiety or agitation**: Some users report increased anxiety, agitation, or irritability. This is particularly concerning given the unknown CNS mechanisms of Fadogia. - **Increased aggression or "edgy" feeling**: Some users describe mood changes that may reflect androgenic effects or general CNS stimulation. - **Muscle cramps**: Occasional reports, possibly related to electrolyte or mineral effects. - **Libido paradox**: Interestingly, some users report DECREASED libido with chronic Fadogia use, contrary to the aphrodisiac reputation. This may reflect HPG axis downregulation with sustained exogenous stimulation — a pattern seen with various testosterone-enhancing agents. **Safety concerns from rodent toxicology (which may or may not apply to humans):** - **Hepatotoxicity (liver damage)**: The Yakubu 2008 rat studydocumented dose-dependent hepatic injury at the same doses that elevated testosterone in the short-term study. Whether analogous hepatotoxicity occurs in humans at commonly used supplement doses is unknown, but the rodent data warrants caution. Patients with pre-existing liver disease should avoid Fadogia; healthy users on extended Fadogia courses should consider periodic liver function monitoring (AST, ALT, bilirubin). - **Nephrotoxicity (kidney damage)**: Same Yakubu 2008 study documented dose-dependent renal injury in rats. Mechanism unclear. Patients with kidney disease should avoid Fadogia; healthy users should consider periodic renal function monitoring (creatinine, BUN, estimated GFR). - **Testicular toxicity**: Perhaps the most ironic and concerning finding of the rodent toxicology: the same organ Fadogia is purported to "support" shows histological damage at doses that elevated testosterone in short-term studies. This raises the question of whether "testosterone boosting" comes at the cost of testicular health with prolonged use. Cycling (4-8 weeks on, 4+ weeks off) is strongly recommended as a precaution. - **Hematologic effects**: Rodent studies showed changes in blood parameters that could reflect bone marrow effects or direct hematologic toxicity. **Population-specific concerns:** - **Pregnancy and lactation**: Contraindicated absolutely. No safety data; traditional use was not in pregnant/lactating women; theoretical hormonal effects could be teratogenic. - **Hormone-sensitive cancers** (prostate, breast, testicular): Avoid. The purported testosterone-elevating effect (whether real or not) would be contraindicated. - **Liver or kidney disease**: Avoid given the rodent toxicity signal in these organs. - **Children and adolescents**: Avoid. Developing reproductive systems should not be exposed to uncharacterized hormonally-active compounds. - **Men planning fertility/conception**: Use with caution or avoid. The testicular toxicity signal in rodents is concerning; theoretical suppression of endogenous HPG axis could impair fertility. - **Hypertension or cardiovascular disease**: Use with caution; effects on blood pressure and cardiovascular function in humans are unknown. - **Mental health conditions** (anxiety, depression, bipolar): Use with caution given anecdotal reports of mood changes. **Drug interactions (theoretical — essentially no formal studies):** - **Testosterone replacement therapy (TRT)**: Redundant and potentially concerning for HPG axis disruption. Do not combine. - **Other testosterone-enhancing supplements** ([Tongkat Ali](/compound/tongkat-ali), [ashwagandha](/compound/ashwagandha), [Tribulus](/compound/tribulus-terrestris), DAA, etc.): Theoretical additive effects; use with caution and prefer not stacking multiple testosterone-claimed supplements simultaneously. - **Anabolic-androgenic steroids (prescription or non-medical)**: Do not combine. - **Hepatotoxic medications**: Avoid given the liver injury signal. Examples include acetaminophen at high doses, isoniazid, methotrexate, amiodarone, statins in susceptible individuals. - **Nephrotoxic medications**: Avoid given the kidney injury signal. Examples include NSAIDs in high doses or chronically, aminoglycoside antibiotics, cyclosporine, certain chemotherapy agents. - **Antihypertensive medications**: Unknown interactions; monitor blood pressure. - **Antidepressants and anxiolytics**: Theoretical interactions given CNS effects; use with caution. - **Blood thinners**: Unknown interactions; monitor for bleeding. **Quality and safety considerations specific to Fadogia:** - **Plant misidentification**: Fadogia agrestis must be distinguished from related *Fadogia* species and from unrelated plants that may be marketed or sold as Fadogia. DNA-authenticated products offer stronger identification guarantee. - **Contamination**: West African plant supply chains may have inconsistent contamination testing for heavy metals, pesticides, and microbial contaminants. - **Adulteration with pharmaceutical hormones or steroids**: While less documented than for Tribulus, the possibility exists, particularly for products aggressively marketing "dramatic testosterone effects." - **Third-party testing**: The infrastructure for Fadogia product testing is less developed than for mainstream supplements. Consumers should preferentially choose brands with documented third-party analytical testing. **Monitoring recommendations for users:** - Baseline comprehensive metabolic panel (CMP) including liver enzymes, BUN, creatinine - Baseline testosterone (total and free), SHBG, estradiol, LH - Follow-up CMP at 6-8 weeks to monitor liver and kidney function - Follow-up hormone panel at 8-12 weeks to assess whether anticipated effects occurred - Discontinue at the first sign of hepatic dysfunction (jaundice, dark urine, RUQ pain, transaminitis) - Discontinue at signs of renal dysfunction (oliguria, peripheral edema, elevated creatinine) - Cycling: strongly recommended — 4-8 weeks on, 4+ weeks off - Avoid prolonged continuous use (>3-4 months without breaks)

    Where can I buy Fadogia Agrestis?

    Visit our vendor directory to find trusted sources for Fadogia Agrestis.

    Free 2026 Peptide Cheat Sheet — 50 pages, PDF

    Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.

    Download Free
    ResearchChemHQ BPC-157 500mcg × 60 capsules bottle
    IN STOCK · COA PER BATCH

    BPC-157 Caps

    60 caps × 500mcg. HPLC + COA on every batch, ≥99% purity. Same molecule as the vials, just oral so it travels. code REDDIT stacks with their 5-vial 20% off and 10-vial 40% off tiers.

    COUPON CODEREDDIT
    Grab a bottle →
    Research use only. Not for human consumption.|BodyHackGuide promotes vendors. We do not sell these products.